Laddar...
Treatment with olaparib monotherapy for BRCA2-mutated refractory intrahepatic cholangiocarcinoma: a case report
Olaparib is an oral poly ADP-ribose polymerase inhibitor with activity in germline BRCA1 and BRCA2 (BRCA1/2)-associated breast and ovarian cancers. There is no report about treatment with olaparib in BRCA1/2-mutated intrahepatic cholangiocarcinomas. This study is to observe the efficacy and safety o...
Sparad:
| I publikationen: | Onco Targets Ther |
|---|---|
| Huvudupphovsmän: | , , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Dove Medical Press
2018
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6151096/ https://ncbi.nlm.nih.gov/pubmed/30271179 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S176914 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|